233 related articles for article (PubMed ID: 25004073)
41. The novel ketoprofen amides--synthesis and biological evaluation as antioxidants, lipoxygenase inhibitors and cytostatic agents.
Rajić Z; Hadjipavlou-Litina D; Pontiki E; Kralj M; Suman L; Zorc B
Chem Biol Drug Des; 2010 Jun; 75(6):641-52. PubMed ID: 20337784
[TBL] [Abstract][Full Text] [Related]
42. 6-Cinnamoyl-4-arylaminothienopyrimidines as highly potent cytotoxic agents: Design, synthesis and structure-activity relationship studies.
Toolabi M; Moghimi S; Bakhshaiesh TO; Salarinejad S; Aghcheli A; Hasanvand Z; Nazeri E; Khalaj A; Esmaeili R; Foroumadi A
Eur J Med Chem; 2020 Jan; 185():111786. PubMed ID: 31671308
[TBL] [Abstract][Full Text] [Related]
43. Cinnamic acid derivatives induce cell cycle arrest in carcinoma cell lines.
Sova M; Žižak Ž; Stanković JA; Prijatelj M; Turk S; Juranić ZD; Mlinarič-Raščan I; Gobec S
Med Chem; 2013 Aug; 9(5):633-41. PubMed ID: 23140579
[TBL] [Abstract][Full Text] [Related]
44. Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies.
Muthuraman S; Sinha S; Vasavi CS; Waidha KM; Basu B; Munussami P; Balamurali MM; Doble M; Saravana Kumar R
Bioorg Med Chem; 2019 Feb; 27(4):604-619. PubMed ID: 30638966
[TBL] [Abstract][Full Text] [Related]
45. Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
Lamie PF; Ali WAM; Bazgier V; Rárová L
Eur J Med Chem; 2016 Nov; 123():803-813. PubMed ID: 27541263
[TBL] [Abstract][Full Text] [Related]
46. Design, synthesis and biological evaluation of di-substituted cinnamic hydroxamic acids bearing urea/thiourea unit as potent histone deacetylase inhibitors.
Ning C; Bi Y; He Y; Huang W; Liu L; Li Y; Zhang S; Liu X; Yu N
Bioorg Med Chem Lett; 2013 Dec; 23(23):6432-5. PubMed ID: 24119555
[TBL] [Abstract][Full Text] [Related]
47. Trioxsalen derivatives with lipoxygenase inhibitory activity.
Hadjipavlou-Litina D; E Bariamis S; Militsopoulou M; Athanassopoulos CM; Papaioannou D
J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1351-6. PubMed ID: 19912068
[TBL] [Abstract][Full Text] [Related]
48. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
49. Easy and rapid preparation of benzoylhydrazides and their diazene derivatives as inhibitors of 15-lipoxygenase.
Tirapegui C; Acevedo-Fuentes W; Dahech P; Torrent C; Barrias P; Rojas-Poblete M; Mascayano C
Bioorg Med Chem Lett; 2017 Apr; 27(8):1649-1653. PubMed ID: 28318946
[TBL] [Abstract][Full Text] [Related]
50. Anti-Cancer Activity of 2,4-Disubstituted Thiophene Derivatives: Dual Inhibitors of Lipoxygenase and Cyclooxygenase.
Rakesh KS; Jagadish S; Swaroop TR; Mohan CD; Ashwini N; Harsha KB; Zameer F; Girish KS; Rangappa KS
Med Chem; 2015; 11(5):462-72. PubMed ID: 25494807
[TBL] [Abstract][Full Text] [Related]
51. Design, synthesis and biological evaluation of cinnamic acyl shikonin derivatives.
Lin HY; Chen W; Shi J; Kong WY; Qi JL; Wang XM; Yang YH
Chem Biol Drug Des; 2013 Feb; 81(2):275-83. PubMed ID: 23066914
[TBL] [Abstract][Full Text] [Related]
52. Novel Pyrimidine Derivatives as Antioxidant and Anticancer Agents: Design, Synthesis and Molecular Modeling Studies.
Myriagkou M; Papakonstantinou E; Deligiannidou GE; Patsilinakos A; Kontogiorgis C; Pontiki E
Molecules; 2023 May; 28(9):. PubMed ID: 37175322
[TBL] [Abstract][Full Text] [Related]
53. Substituted furans as potent lipoxygenase inhibitors: Synthesis, in vitro and molecular docking studies.
Vinayagam J; Gajbhiye RL; Mandal L; Arumugam M; Achari A; Jaisankar P
Bioorg Chem; 2017 Apr; 71():97-101. PubMed ID: 28143657
[TBL] [Abstract][Full Text] [Related]
54. Design and Synthesis of Molecular Hybrids of Sophora Alkaloids and Cinnamic Acids as Potential Antitumor Agents.
Shang H; Li L; Ma L; Tian Y; Jia H; Zhang T; Yu M; Zou Z
Molecules; 2020 Mar; 25(5):. PubMed ID: 32150948
[TBL] [Abstract][Full Text] [Related]
55. Pyrazole Derivatives of Medically Relevant Phenolic Acids: Insight into Antioxidative and Anti-LOX Activity.
Milovanović V; Petrović ZD; Novaković S; Bogdanović GA; Simijonović D; Mladenović M; Branković J; Petrović VP
Med Chem; 2021; 17(8):807-819. PubMed ID: 32484771
[TBL] [Abstract][Full Text] [Related]
56. Antioxidant and antimicrobial activities of cinnamic acid derivatives.
Sova M
Mini Rev Med Chem; 2012 Jul; 12(8):749-67. PubMed ID: 22512578
[TBL] [Abstract][Full Text] [Related]
57. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
58. Pyrazoline analogs as potential anticancer agents and their apoptosis, molecular docking, MD simulation, DNA binding and antioxidant studies.
Rana M; Arif R; Khan FI; Maurya V; Singh R; Faizan MI; Yasmeen S; Dar SH; Alam R; Sahu A; Ahmad T; Rahisuddin
Bioorg Chem; 2021 Mar; 108():104665. PubMed ID: 33571809
[TBL] [Abstract][Full Text] [Related]
59. Multitarget molecular hybrids of cinnamic acids.
Peperidou A; Kapoukranidou D; Kontogiorgis C; Hadjipavlou-Litina D
Molecules; 2014 Dec; 19(12):20197-226. PubMed ID: 25474291
[TBL] [Abstract][Full Text] [Related]
60. Dicoumarol derivatives: Green synthesis and molecular modelling studies of their anti-LOX activity.
Simijonović D; Vlachou EE; Petrović ZD; Hadjipavlou-Litina DJ; Litinas ΚE; Stanković N; Mihović N; Mladenović MP
Bioorg Chem; 2018 Oct; 80():741-752. PubMed ID: 30077781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
